Search Result

Isoforms Recommended:	Oxazolidinone

Results for "

oxazolidinone

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Antibiotic (29) Bacterial (30) Biochemical Assay Reagents (5) Drug Intermediate (1) Drug Metabolite (5) Isotope-Labeled Compounds (8) Monoamine Oxidase (3) NF-κB (1) Opioid Receptor (1) Reference Standards (10) Ser/Thr Protease (1)
By Research Areas:	Cancer (2) Cardiovascular Disease (1) Infection (35) Inflammation/Immunology (6) Metabolic Disease (2)

Inhibitors & Agonists

Biochemical Assay Reagents

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-W012982

3-Amino-2-oxazolidinone AOZ	Drug Metabolite Monoamine Oxidase	Cardiovascular Disease Metabolic Disease
3-Amino-2-oxazolidinone (AOZ) is the metabolite of Furazolidone (HY-B1336). 3-Amino-2-oxazolidinone is always be detected as a indicator of furazolidone residues in vivo. 3-Amino-2-oxazolidinone is orally active .

HY-W002062

(S)-4-Isopropyl-2-oxazolidinone	Biochemical Assay Reagents	Others
(S)-4-Isopropyl-2-oxazolidinone is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-W007664

(R)-4-Benzyl-2-oxazolidinone	Biochemical Assay Reagents	Others
(R)-4-Benzyl-2-oxazolidinone is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-W012982S

*3-Amino-2-oxazolidinone-d4* AOZ-d₄	Drug Metabolite	Others
3-Amino-2-oxazolidinone-d₄ is a deuterium labeled 3-Amino-2-oxazolidinone. 3-Amino-2-oxazolidinone (AOZ) is the metabolite of Furazolidone (HY-B1336). 3-Amino-2-oxazolidinone is always be detected as an indicator of furazolidone residues .

HY-41882

(S)-4-Benzyl-2-oxazolidone (-)-4-Benzyl-2-oxazolidinone	Biochemical Assay Reagents	Others
(S)-4-Benzyl-2-oxazolidinone is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-135397

(R)-Linezolid (R)-PNU-100766	Drug Metabolite	Infection
(R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis .

HY-W012982R

*3-Amino-2-oxazolidinone* (Standard)** AOZ (Standard)	Reference Standards Drug Metabolite	Metabolic Disease
3-Amino-2-oxazolidinone (Standard) is the analytical standard of 3-Amino-2-oxazolidinone. This product is intended for research and analytical applications. 3-Amino-2-oxazolidinone (AOZ) is the metabolite of Furazolidone (HY-B1336). 3-Amino-2-oxazolidinone is always be detected as a indicator of furazolidone residues in vivo .

HY-132672S

*(4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone-d3*	Isotope-Labeled Compounds	Others
(4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone-d₃ is the deuterium labeled (4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone .

HY-167892

DRF-8417	Antibiotic Bacterial	Infection Inflammation/Immunology
DRF-8417, an oxazolidinone antibiotic, is active against Gram-positive and fastidious Gram-negative bacteria. DRF 8417 exhibits potent activity against Gram-positive pathogens with MIC₅₀ and MIC₉₀ values ranging from 0.06 to 1 mg/L .

HY-138181

Contezolid phosphoramidic acid MRX-I phosphoramidic acid	Drug Intermediate	Others
Contezolid phosphoramidic acid is an intermediate in the synthesis of proagents of antibacterial oxazolidinone agent MRX-I. Contezolid phosphoramidic acid is extracted from patent WO2015127316A1, Intermediate 3, Method I .

HY-139398

TBI-223 1 Publications Verification	Antibiotic Bacterial	Infection
TBI-223 is an orally bioavailable oxazolidinone antibiotic and an antimicrobial. TBI-223 shows activity against Mycobacterium tuberculosis (Mtb) .

HY-141723S

*(4R,5R)-5-(2,4-Difluorophenyl)-4-methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-2-oxazolidinone-d3*	Isotope-Labeled Compounds	Others
(4R,5R)-5-(2,4-Difluorophenyl)-4-methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-2-oxazolidinone-d₃ is the deuterium labeled (4R,5R)-5-(2,4-Difluorophenyl)-4-methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-2-oxazolidinone .

HY-135397R

(R)-?Linezolid (Standard) (R)-PNU-100766 (Standard)	Drug Metabolite Reference Standards	Infection
(R)-Linezolid (Standard) is the analytical standard of (R)-Linezolid. This product is intended for research and analytical applications. (R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis .

HY-15993

Posizolid AZD2563; AZD5847	Antibiotic	Infection
Posizolid (AZD2563), an oxazolidinone antibiotic, is developed by AstraZeneca for the study of bacterial infections. Posizolid shows very good anti-mycobacterial activity .

HY-W750774

(R)-4-Benzyl-3-propionyloxazolidin-2-one-d3 N-3-propionyl-(4R)-benzyl-2-oxazolidinone-d₃	Isotope-Labeled Compounds	Others
(R)-4-Benzyl-3-propionyloxazolidin-2-one-d₃ (N-3-propionyl-(4R)-benzyl-2-oxazolidinone-d₃) is the deuterium labeled (R)-4-Benzyl-3-propionyloxazolidin-2-one (HY-W008773).

HY-W741021

(S)-4-Benzyl-3-propionyloxazolidin-2-one-d3 2-oxazolidinone, 3-(1-oxopropyl)-4-(phenylmethyl)-, (4S)-d₃	Isotope-Labeled Compounds	Others
(S)-4-Benzyl-3-propionyloxazolidin-2-one-d₃ (2-Oxazolidinone, 3-(1-oxopropyl)-4-(phenylmethyl)-, (4S)-d₃) is the deuterium labeled (S)-4-Benzyl-3-propionyloxazolidin-2-one (HY-W008304).

HY-10392

Sutezolid 4 Publications Verification PNU-100480; U-100480; PF-02341272	Bacterial Antibiotic	Infection
Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis .

HY-10392R

Sutezolid (Standard) PNU-100480 (Standard); U-100480 (Standard); PF-02341272 (Standard)	Reference Standards Bacterial Antibiotic	Infection
Sutezolid (Standard) is the analytical standard of Sutezolid. This product is intended for research and analytical applications. Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis[1][2].

HY-167841

Anti-MRSA agent 19	Bacterial Antibiotic	Infection
Anti-MRSA agent 19 (Compound 1) is an antibiotic that exhibits activity against S. aureus. Anti-MRSA agent 19 is a active (median MIC=4 μg/mL) against 40 CDC isolates of different bacterial species containing various resistance factors，including Vancomycin (HY-B0671)，aminoglycoside/Tetracycline (HY-A0107)，and oxazolidinone resistance .

HY-172619

BS-153	NF-κB	Inflammation/Immunology
BS-153 is a novel synthetic oxazolidinone agent with anti-inflammatory activities by blocking the activation of the NF-κB/PKCθ pathway. BS-153 inhibits the expression levels of iNOS and COX-2 and pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) on LPS-stimulated RAW264.7 cells .

HY-101818

PNU288034	Antibiotic Bacterial	Infection
PNU288034 is a potent oxazolidinone antibiotic.

HY-125074

PNU 142300	Antibiotic	Infection
PNU 142300 is an inactive metabolite of the oxazolidinone antibiotic Linezolid (HY-10394).

HY-101819

Antibacterial compound 1	Bacterial	Infection
Antibacterial compound 1 is a oxazolidinone extracted from patent WO1999037630A1 with antibacterial activities.

HY-100436

Cadazolid ACT-179811	Bacterial Antibiotic	Infection
Cadazolid (ACT-179811) is a new oxazolidinone antibiotic with potent activity against Clostridium difficile.

HY-111056

UK122	Ser/Thr Protease	Cancer
UK122 is a potent and selective urokinase-type plasminogen activator (uPA) inhibitor with an IC₅₀ of 0.2 μM. UK122 shows no or little inhibition of tissue-type PA (tPA), plasmin, thrombin, and trypsin (all IC₅₀>100 μM). UK122, 4-oxazolidinone analogue, is an anticancer agent and inhibits cancer cell migration and invasion .

HY-14855A

(S)-Tedizolid 2 Publications Verification (S)-TR 700; (S)-DA 7157	Bacterial Antibiotic	Infection
(S)-Tedizolid is the S-enantiomer of Tedizolid. Tedizolid is a novel oxazolidinone with activity against Gram-positive pathogens. (S)-Tedizolid is the less active isomer.

HY-100180

Delpazolid 1 Publications Verification LCB01-0371	Bacterial Antibiotic	Infection
Delpazolid is a novel oxazolidinone antibiotic agent which can inhibit the growth of MSSA and MRSA with a MIC₉₀ of 2 μg/mL for both of them.

HY-101726

DuP 105	Antibiotic Bacterial	Infection
DuP 105 is an orally active oxazolidinone with activity against Gram-positive bacteria. DuP 105 protects staphylococcal and streptococcal infections in mice .

HY-W019727

(S)-4-Phenyloxazolidin-2-one (S)-(+)-4-Phenyl-2-oxazolidinone	Biochemical Assay Reagents	Others
(S)-4-Phenyloxazolidin-2-one is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-10393R

Eperezolid (Standard) PNU-100592 (Standard)	Reference Standards Bacterial Antibiotic	Infection
Eperezolid (Standard) is an analytical standard for Eperezolid. This product is intended for research and analytical applications. Eperezolid (PNU-100592) is an oxazolidinone antibiotic with good in vitro inhibitory properties.

HY-122123

S-6123	Bacterial Antibiotic	Infection
S-6123 is a potent antimicrobial compound of the oxazolidinone series. S-6123 inhibits ribosomal protein synthesis without inhibiting DNA or RNA synthesis .

HY-14800

Radezolid 5+ Cited Publications RX-1741	Bacterial Antibiotic	Infection
Radezolid (RX-1741) is a oxazolidinone antibiotic. Radezolid is active against *Staphylococcus, Chlamydia, and Legionella* species, and remains active against Linezolid-resistant strains .

HY-100436R

Cadazolid (Standard) ACT-179811 (Standard)	Reference Standards Bacterial Antibiotic	Infection
Cadazolid (Standard) is the analytical standard of Cadazolid. This product is intended for research and analytical applications. Cadazolid (ACT-179811) is a new oxazolidinone antibiotic with potent activity against Clostridium difficile.

HY-W019727R

(S)-4-Phenyloxazolidin-2-one (Standard) (S)-(+)-4-Phenyl-2-oxazolidinone (Standard)	Biochemical Assay Reagents Reference Standards	Others
(S)-4-Phenyloxazolidin-2-one (Standard) is the analytical standard of (S)-4-Phenyloxazolidin-2-one. This product is intended for research and analytical applications. (S)-4-Phenyloxazolidin-2-one is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-14855

Tedizolid 10+ Cited Publications TR 700; Torezolid; DA-7157	Bacterial Antibiotic	Infection
Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA) of the 50S subunit of the ribosome.

HY-113687

T145	Bacterial	Infection
T145 is an oxazolidinone with antibacterial activity that inhibits growth of gram negatives (K. pneumoniae, A. baumannii, P. aeruginosa and E. cloacae), gram positives (E. faecalis and S. aureus) and acid fast pathogens (Mab, Mav and Mtb) .

HY-14855AR

(S)-Tedizolid (Standard) (S)-TR 700 (Standard); (S)-DA 7157 (Standard)	Reference Standards Bacterial Antibiotic	Infection
(S)-Tedizolid (Standard) is the analytical standard of (S)-Tedizolid. This product is intended for research and analytical applications. (S)-Tedizolid is the S-enantiomer of Tedizolid. Tedizolid is a novel oxazolidinone with activity against Gram-positive pathogens. (S)-Tedizolid is the less active isomer.

HY-19915A

Contezolid acefosamil MRX-4	Bacterial Antibiotic	Infection Inflammation/Immunology
Contezolid acefosamil (MRX-4) is the orally active proagent of the active antimicrobial metabolite Contezolid (MRX-I), an oxazolidinone which shows potent in vitro activity against various multidrug-resistant Gram-positive bacteria, including MRSA .

HY-14800R

Radezolid (Standard) RX-1741 (Standard)	Reference Standards Bacterial Antibiotic	Infection
Radezolid (Standard) is the analytical standard of Radezolid. This product is intended for research and analytical applications. Radezolid (RX-1741) is a oxazolidinone antibiotic. Radezolid is active against Staphylococcus, Chlamydia, and Legionella species, and remains active against Linezolid-resistant strains[1][2].

HY-19915

Contezolid 2 Publications Verification MRX-I	Bacterial Antibiotic Monoamine Oxidase	Infection Inflammation/Immunology
Contezolid (MRX-I), a new and orally active oxazolidinone, is an antibiotic in study for complicated skin and soft tissue infections (cSSTI) caused by resistant Gram-positive bacteria. Contezolid (MRX-I) markedly reduces potential for myelosuppression and monoamine oxidase inhibition (MAOI) .

HY-10394

Linezolid Maximum Cited Publications 38 Publications Verification PNU-100766	Bacterial Antibiotic	Infection Cancer
Linezolid (PNU-100766) is the first member of the class of oxazolidinone synthetic antibiotic. Linezolid acts by inhibiting the initiation of bacterial protein synthesis. Linezolid is used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics .

HY-163486

Antituberculosis agent-10	Bacterial	Infection
Antituberculosis agent-10 (Compound 9) has excellent antibacterial activity against *Mycobacterium tuberculosis* (MIC = 0.3 μM). Antituberculosis agent-10 inhibits protein synthesis by targeting the 50S ribosomal subunit of the bacterium, thus exerting its antibacterial effect. Antituberculosis agent-10 is orally active .

HY-14855R

Tedizolid (Standard) TR 700 (Standard); Torezolid (Standard); DA-7157 (Standard)	Reference Standards Bacterial Antibiotic	Infection
Tedizolid (Standard) is the analytical standard of Tedizolid. This product is intended for research and analytical applications. Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA) of the 50S subunit of the ribosome.

HY-19915B

Contezolid acefosamil sodium MRX-4 sodium	Bacterial Antibiotic Monoamine Oxidase	Infection Inflammation/Immunology
Contezolid acefosamil sodium (MRX-4), a new and orally active oxazolidinone, is an antibiotic in study for complicated skin and soft tissue infections (cSSTI) caused by resistant Gram-positive bacteria. Contezolid acefosamil sodium (MRX-4) markedly reduces potential for myelosuppression and monoamine oxidase inhibition (MAOI) .

HY-14855S

Tedizolid-13C,d3 TR 700-¹³C,d₃; Torezolid-¹³C,d₃; DA-7157-¹³C,d₃	Isotope-Labeled Compounds Bacterial Antibiotic	Infection
Tedizolid- ¹³C,d₃ is the ¹³C- and deuterium labeled Tedizolid. Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA) of the 50S subunit of the ribosome.

HY-135397S

(R)-Linezolid-d3	Isotope-Labeled Compounds	Infection
(R)-Linezolid-d₃ ((R)-PNU-100766-d₃) is the deuterium labeled (R)-?Linezolid. (R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis .

HY-10392S

Sutezolid-13C4 PNU-100480-¹³C₄; U-100480-¹³C₄; PF-02341272-¹³C₄	Isotope-Labeled Compounds Antibiotic Bacterial	Infection
Sutezolid- ¹³C₄ (PNU-100480- ¹³C₄) is ¹³C labeled Sutezolid. Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis .

HY-10394R

Linezolid (Standard) PNU-100766 (Standard)	Reference Standards Bacterial Antibiotic	Infection
Linezolid (Standard) is the analytical standard of Linezolid. This product is intended for research and analytical applications. Linezolid (PNU-100766) is the first member of the class of oxazolidinone synthetic antibiotic. Linezolid acts by inhibiting the initiation of bacterial protein synthesis. Linezolid is used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics .

HY-10394S1

PNU-100766-d8 PNU-100766-d8	Antibiotic Bacterial Isotope-Labeled Compounds	Infection
PNU-100766-d₈ is deuterated labeled Linezolid (HY-10394). Linezolid (PNU-100766) is the first member of the class of oxazolidinone synthetic antibiotic. Linezolid acts by inhibiting the initiation of bacterial protein synthesis. Linezolid is used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics .

HY-160761

K-Opioid receptor agonist-1	Opioid Receptor	Inflammation/Immunology
K-Opioid receptor agonist-1 (Compound 5a) is an agonist for κ-Opioid receptor with K_i of 0.25 nM and EC₅₀ of 2 nM. K-Opioid receptor agonist-1 is blood brain barrier (BBB) penetrate (brain/plasma ratios of 0.50 to 0.65). K-Opioid receptor agonist-1 exhibits anti-inflammatory activity in dermatitis models induced by Arachidonic acid (HY-109590) or oxazolidinone .

Cat. No.	Product Name	Type

HY-W002062

(S)-4-Isopropyl-2-oxazolidinone	Biochemical Assay Reagents
(S)-4-Isopropyl-2-oxazolidinone is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-W007664

(R)-4-Benzyl-2-oxazolidinone	Biochemical Assay Reagents
(R)-4-Benzyl-2-oxazolidinone is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-41882

(S)-4-Benzyl-2-oxazolidone (-)-4-Benzyl-2-oxazolidinone	Biochemical Assay Reagents
(S)-4-Benzyl-2-oxazolidinone is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-W019727

(S)-4-Phenyloxazolidin-2-one (S)-(+)-4-Phenyl-2-oxazolidinone	Biochemical Assay Reagents
(S)-4-Phenyloxazolidin-2-one is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-W019727R

(S)-4-Phenyloxazolidin-2-one (Standard) (S)-(+)-4-Phenyl-2-oxazolidinone (Standard)	Biochemical Assay Reagents
(S)-4-Phenyloxazolidin-2-one (Standard) is the analytical standard of (S)-4-Phenyloxazolidin-2-one. This product is intended for research and analytical applications. (S)-4-Phenyloxazolidin-2-one is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

Cat. No.	Product Name	Chemical Structure

HY-W012982S

*3-Amino-2-oxazolidinone-d4*
3-Amino-2-oxazolidinone-d₄ is a deuterium labeled 3-Amino-2-oxazolidinone. 3-Amino-2-oxazolidinone (AOZ) is the metabolite of Furazolidone (HY-B1336). 3-Amino-2-oxazolidinone is always be detected as an indicator of furazolidone residues .

HY-132672S

*(4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone-d3*
(4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone-d₃ is the deuterium labeled (4S)-3-[(2R)-2-[(2R)-2-(2,4-Difluorophenyl)oxiranyl]-1-oxopropyl]-4-benzyl-2-oxazolidinone .

HY-141723S

*(4R,5R)-5-(2,4-Difluorophenyl)-4-methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-2-oxazolidinone-d3*
(4R,5R)-5-(2,4-Difluorophenyl)-4-methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-2-oxazolidinone-d₃ is the deuterium labeled (4R,5R)-5-(2,4-Difluorophenyl)-4-methyl-5-(1H-1,2,4-triazol-1-ylmethyl)-2-oxazolidinone .

HY-W750774

(R)-4-Benzyl-3-propionyloxazolidin-2-one-d3
(R)-4-Benzyl-3-propionyloxazolidin-2-one-d₃ (N-3-propionyl-(4R)-benzyl-2-oxazolidinone-d₃) is the deuterium labeled (R)-4-Benzyl-3-propionyloxazolidin-2-one (HY-W008773).

HY-W741021

(S)-4-Benzyl-3-propionyloxazolidin-2-one-d3
(S)-4-Benzyl-3-propionyloxazolidin-2-one-d₃ (2-Oxazolidinone, 3-(1-oxopropyl)-4-(phenylmethyl)-, (4S)-d₃) is the deuterium labeled (S)-4-Benzyl-3-propionyloxazolidin-2-one (HY-W008304).

HY-14855S

Tedizolid-13C,d3
Tedizolid- ¹³C,d₃ is the ¹³C- and deuterium labeled Tedizolid. Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA) of the 50S subunit of the ribosome.

HY-135397S

(R)-Linezolid-d3
(R)-Linezolid-d₃ ((R)-PNU-100766-d₃) is the deuterium labeled (R)-?Linezolid. (R)-Linezolid is an impurity of Linezolid (PNU-100766). Linezolid, the first member of the class of oxazolidinone synthetic antibiotic, acts by inhibiting the initiation of bacterial protein synthesis .

HY-10392S

Sutezolid-13C4
Sutezolid- ¹³C₄ (PNU-100480- ¹³C₄) is ¹³C labeled Sutezolid. Sutezolid (PNU-100480), an orally active oxazolidinone antimicrobial agent, acts by inhibiting bacterial protein synthesis. Sutezolid has potent activity against mycobacteria, and is used for the research of drug-resistant tuberculosis .

HY-10394S1

PNU-100766-d8
PNU-100766-d₈ is deuterated labeled Linezolid (HY-10394). Linezolid (PNU-100766) is the first member of the class of oxazolidinone synthetic antibiotic. Linezolid acts by inhibiting the initiation of bacterial protein synthesis. Linezolid is used for the treatment of serious infections caused by Gram-positive bacteria that are resistant to several other antibiotics .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: